74 related articles for article (PubMed ID: 2303274)
1. A probabilistic approach to the single-point, single-dose problem.
Briggs WL; Phelps RW; Swanson GD
IEEE Trans Biomed Eng; 1990 Jan; 37(1):80-4. PubMed ID: 2303274
[TBL] [Abstract][Full Text] [Related]
2. An estimation method of the clearance for a one-compartment model of a single bolus intravenous injection by a single sampling.
Funatogawa T; Funatogawa I
J Biopharm Stat; 2012; 22(1):43-53. PubMed ID: 22204526
[TBL] [Abstract][Full Text] [Related]
3. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
Zhou H; Mayer PR; Wajdula J; Fatenejad S
J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
[TBL] [Abstract][Full Text] [Related]
4. A point estimator for the time course of drug release.
Koehne-Voss S; Pigeot I
Biom J; 2009 Feb; 51(1):146-58. PubMed ID: 19219906
[TBL] [Abstract][Full Text] [Related]
5. Choosing optimal sampling times for therapeutic drug monitoring.
Schumacher GE
Clin Pharm; 1985; 4(1):84-92. PubMed ID: 3971691
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling.
Gibson CR; Bergman A; Lu P; Kesisoglou F; Denney WS; Mulrooney E
Xenobiotica; 2009 Sep; 39(9):637-48. PubMed ID: 19480559
[TBL] [Abstract][Full Text] [Related]
7. Model-free evaluation and mean-time concept in pharmacokinetics.
Brockmeier D
Methods Find Exp Clin Pharmacol; 1986 Oct; 8(10):593-602. PubMed ID: 3784698
[TBL] [Abstract][Full Text] [Related]
8. Parabolic quantitative structure-activity relationships and photodynamic therapy: application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivatives used as photosensitizers for photodynamic therapy.
Potter WR; Henderson BW; Bellnier DA; Pandey RK; Vaughan LA; Weishaupt KR; Dougherty TJ
Photochem Photobiol; 1999 Nov; 70(5):781-8. PubMed ID: 10568170
[TBL] [Abstract][Full Text] [Related]
9. Criticism of pharmacokinetic clearance concepts.
Keller F; Schoole J
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):563-8. PubMed ID: 6654532
[TBL] [Abstract][Full Text] [Related]
10. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
[TBL] [Abstract][Full Text] [Related]
11. [Advances and related issues in the use of in vitro methods to predict metabolic clearance rate of new drugs].
Zhang Q; Wang GJ
Yao Xue Xue Bao; 2007 Oct; 42(10):1023-8. PubMed ID: 18229605
[TBL] [Abstract][Full Text] [Related]
12. An APL computer program for estimating rate constants of drug absorption.
Zeng YL; Akkermans AA; van Waning WE; Breimer DD
Arzneimittelforschung; 1983; 33(6):902-4. PubMed ID: 6688530
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
Kortejärvi H; Urtti A; Yliperttula M
Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
[TBL] [Abstract][Full Text] [Related]
14. Development of an optimal pharmacokinetic sampling schedule for rubitecan administered orally in a daily times five schedule.
Schoemaker NE; Mathôt RA; Schöffski P; Rosing H; Schellens JH; Beijnen JH
Cancer Chemother Pharmacol; 2002 Dec; 50(6):514-7. PubMed ID: 12451480
[TBL] [Abstract][Full Text] [Related]
15. Probabilistic analysis of preload in the abutment screw of a dental implant complex.
Guda T; Ross TA; Lang LA; Millwater HR
J Prosthet Dent; 2008 Sep; 100(3):183-93. PubMed ID: 18762030
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting the error in the Loo-Riegelman method for estimating the rate of drug absorption. Some suggestions for a practical sampling schedule.
Zeng YL; Akkermans AA; Breimer DD
Arzneimittelforschung; 1983; 33(5):757-60. PubMed ID: 6688184
[TBL] [Abstract][Full Text] [Related]
17. Effect of infusion rate on thiopental dose-response relationships. Assessment of a pharmacokinetic-pharmacodynamic model.
Gentry WB; Krejcie TC; Henthorn TK; Shanks CA; Howard KA; Gupta DK; Avram MJ
Anesthesiology; 1994 Aug; 81(2):316-24; discussion 25A. PubMed ID: 8053580
[TBL] [Abstract][Full Text] [Related]
18. A minimax approach to the single-point method of drug dosing.
Bahn MM; Landaw EM
J Pharmacokinet Biopharm; 1987 Jun; 15(3):255-69. PubMed ID: 3668803
[TBL] [Abstract][Full Text] [Related]
19. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
Fagerholm U
J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics III: design, analysis, and application of population pharmacokinetic Studies.
Ette EI; Williams PJ; Lane JR
Ann Pharmacother; 2004 Dec; 38(12):2136-44. PubMed ID: 15507495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
